Mengcui J. Gui

Hubei Key Laboratory Of Neural Injury And Functional Reconstruction
Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.

Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.

Journal: Annals of clinical and translational neurology

Published: May 12, 2026

HMGB1-mediated endoplasmic reticulum stress in monocyte-derived dendritic cells regulates CD4+ T cell immune responses in myasthenia gravis.

HMGB1-mediated endoplasmic reticulum stress in monocyte-derived dendritic cells regulates CD4+ T cell immune responses in myasthenia gravis.

Journal: Journal of neuroinflammation

Published: March 19, 2026

Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.

Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.

Journal: The American journal of case reports

Published: February 09, 2026

Add-On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real-World Case Series.

Add-On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real-World Case Series.

Journal: Brain and behavior

Published: October 21, 2025

The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis.

The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis.

Journal: Cellular immunology

Published: March 01, 2025

Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.

Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.

Journal: Therapeutic advances in neurological disorders

Published: December 10, 2024

Guillain-Barré Syndrome During the Outbreak of Omicron in Southern China: A Multicenter Case-Control Study.

Guillain-Barré Syndrome During the Outbreak of Omicron in Southern China: A Multicenter Case-Control Study.

Journal: Journal of inflammation research

Published: October 28, 2024

Long-term efficacy and safety of tacrolimus in anti-MuSK antibody-positive myasthenia gravis: a retrospective single-center cohort study.

Long-term efficacy and safety of tacrolimus in anti-MuSK antibody-positive myasthenia gravis: a retrospective single-center cohort study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 22, 2024

Sleep disturbances in patients with myasthenia gravis: A cross-sectional study.

Sleep disturbances in patients with myasthenia gravis: A cross-sectional study.

Journal: Neurologia

Published: July 03, 2024

Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.

Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.

Journal: Journal of inflammation research

Published: April 26, 2024

Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study.

Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study.

Journal: Rheumatology (Oxford, England)

Published: April 25, 2024

Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study.

Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study.

Journal: Therapeutic advances in neurological disorders

Published: December 12, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026